In this study, we introduced the MLL mutation into bladder cancer transitional cell line T24 and confirmed that the mutation didn't influence the expression of MLL but increased the H3K4me3 modification in GATA4 and ETS1 promoters and the expression levels of GATA4 and ETS1. The gene discussed is ETS1; the disease is urinary bladder carcinoma.